{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:53:09Z","timestamp":1791341589533,"version":"4.3.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009820","name":"Assistance publique-H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jcyt.2013.11.011","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T09:01:43Z","timestamp":1389776503000},"page":"245-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":269,"title":["Phase I trial: the use of autologous cultured adipose-derived stroma\/stem cells to treat patients with non-revascularizable critical limb ischemia"],"prefix":"10.1016","volume":"16","author":[{"given":"Alessandra","family":"Bura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Planat-Benard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bourin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Sebastien","family":"Silvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Grolleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Saint-Lebese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie-Anne","family":"Peyrafitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Gadelorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Taurand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dupuis-Coronas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Leobon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Casteilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2013.11.011_bib1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jvs.2011.10.089","article-title":"Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement","volume":"55","author":"Benoit","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcyt.2013.11.011_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jvs.2012.03.255","article-title":"Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia","volume":"56","author":"Powell","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcyt.2013.11.011_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2013.11.011_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","article-title":"Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial","volume":"92","author":"Lu","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcyt.2013.11.011_bib5","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1161\/01.CIR.0000128596.49339.05","article-title":"Therapeutic angiogenesis and vasculogenesis for ischemic disease, part ii: cell-based therapies","volume":"109","author":"Losordo","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcyt.2013.11.011_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00380-008-1140-z","article-title":"Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease","volume":"24","author":"De Haro","year":"2009","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jcyt.2013.11.011_bib7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/01.RES.0000265074.83288.09","article-title":"Adipose-derived stem cells for regenerative medicine","volume":"100","author":"Gimble","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jcyt.2013.11.011_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000114522.38265.61","article-title":"Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives","volume":"109","author":"Planat-Benard","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcyt.2013.11.011_bib9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","article-title":"Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells","volume":"109","author":"Rehman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcyt.2013.11.011_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/ATVBAHA.108.166496","article-title":"Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis","volume":"29","author":"Kondo","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcyt.2013.11.011_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000094140","article-title":"Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia","volume":"17","author":"Moon","year":"2006","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jcyt.2013.11.011_bib12","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/01.ATV.0000190701.92007.6d","article-title":"Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells","volume":"25","author":"Nakagami","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcyt.2013.11.011_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbrc.2005.04.135","article-title":"Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo","volume":"332","author":"Cao","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcyt.2013.11.011_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/157488810791268546","article-title":"Vascular and endothelial regeneration","volume":"5","author":"Casteilla","year":"2010","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2013.11.011_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1159\/000110447","article-title":"Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia","volume":"20","author":"Kim","year":"2007","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jcyt.2013.11.011_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/14653249.2010.549122","article-title":"Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy","volume":"13","author":"Ikegame","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2013.11.011_bib17","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1253\/circj.CJ-11-0246","article-title":"Gene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrow","volume":"75","author":"Nakanishi","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.jcyt.2013.11.011_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.stem.2011.12.005","article-title":"Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells","volume":"10","author":"Sensebe","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2013.11.011_bib19","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/art.37960","article-title":"Long-term detection of human adipose derived mesenchymal stem cells after intra-articular injection","volume":"65","author":"Toupet","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcyt.2013.11.011_bib20","first-page":"S1","article-title":"Management of peripheral arterial disease (pad): TASC working group: Transatlantic inter-society consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcyt.2013.11.011_bib21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.avsg.2011.11.005","article-title":"Buerger's disease","volume":"26","author":"Dargon","year":"2012","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jcyt.2013.11.011_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.onc.1205070","article-title":"Clinical utility of telomerase in cancer","volume":"21","author":"Hiyama","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jcyt.2013.11.011_bib23","doi-asserted-by":"crossref","first-page":"e49693","DOI":"10.1371\/journal.pone.0049693","article-title":"Oct4 positively regulates survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2013.11.011_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3892\/or.2012.2086","article-title":"Oct4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion","volume":"29","author":"Dai","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jcyt.2013.11.011_bib25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ahj.2008.06.025","article-title":"Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (therapeutic angiogenesis by cell transplantation [tact] trial) in patients with chronic limb ischemia","volume":"156","author":"Matoba","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcyt.2013.11.011_bib26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.jcyt.2013.11.011_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ijo.2010.269","article-title":"Native human adipose stromal cells: localization, morphology and phenotype","volume":"35","author":"Maumus","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jcyt.2013.11.011_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"Bourin","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2013.11.011_bib29","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1200\/JCO.2008.17.0266","article-title":"\u201cStemness\u201d genomics law governs clinical behavior of human cancer: implications for decision making in disease management","volume":"26","author":"Glinsky","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcyt.2013.11.011_bib30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbrc.2007.09.058","article-title":"The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF","volume":"363","author":"Sadat","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcyt.2013.11.011_bib31","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1634\/stemcells.2007-0388","article-title":"Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization","volume":"25","author":"Cai","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2013.11.011_bib32","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/DCR.0b013e318255364a","article-title":"Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: Fistula Advanced Therapy Trial 1) and long-term evaluation","volume":"55","author":"Herreros","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jcyt.2013.11.011_bib33","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1253\/circj.CJ-11-1135","article-title":"Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia","volume":"76","author":"Lee","year":"2012","journal-title":"Circ J"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2013.11.011_bib34","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324913007846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324913007846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:19:21Z","timestamp":1761430761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324913007846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1465324913007846"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2013.11.011","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I trial: the use of autologous cultured adipose-derived stroma\/stem cells to treat patients with non-revascularizable critical limb ischemia","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2013.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}